Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.46 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB | P05771 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | PRKCH | P24723 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16187995 | 1.00 | SPHK1 (0.62) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL29169783 | 0.94 | SPHK1 (0.69) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL7757196 | 0.91 | SPHK1 (0.66) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL16187997 | 0.86 | USP2 (0.69) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL9117099 | 0.86 | SPHK1 (0.61) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL16187998 | 0.86 | USP2 (0.69) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL14880189 | 0.86 | SPHK1 (0.61) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL28128054 | 0.86 | USP2 (0.69) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL29169743 | 0.85 | SPHK1 (0.65) | SPHK1USP2HTTMEN1THRB | |
| SCHEMBL11302893 | 0.83 | SPHK1 (0.58) | SPHK1USP2HTTMEN1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017180453-A1 | FRAGRANCE COMPOSITION | UNGERER AND COMPANY (US) | 2017-10-19 | — | — | WO | disclosed |
| US-9650321-B2 | Renewable surfactants derived from sugar alcohols | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-05-16 | — | — | US | disclosed |
| US-20140316148-A1 | Renewable Surfactants Derived from Sugar Alcohols | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-10-23 | — | — | US | disclosed |
| EP-2475249-A2 | USE OF GLYCEROL ETHERS AS ACTIVATORS OF THE BIOLOGICAL EFFECTS OF A HERBICIDE, FUNGICIDE OR INSECTICIDE SUBSTANCE | Fonds de Developpement des Filières des Oleagineux et Proteagineux (FIDOP) (FR) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011030061-A2 | USE OF GLYCEROL ETHERS AS ACTIVATORS OF THE BIOLOGICAL EFFECTS OF A HERBICIDE, FUNGICIDE OR INSECTICIDE SUBSTANCE | FONDS DE DEVELOPPEMENT DES FILIERES DES OLEAGINEUX ET PROTEAGINEUX (FIDOP) (FR) | 2011-03-17 | — | — | WO | disclosed |
| US-7196052-B2 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140316148-A1 | Renewable Surfactants Derived from Sugar Alcohols | SORD, TREH, MGAM | SPHK1 351/4885USP2 1147/4885HTT 714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.